公开(公告)号：US20070243272A1

公开(公告)日：2007-10-18

申请号：US11677018

申请日：2007-02-20

申请人： Reddy Sastry Cherukuri ,  Rukmini Cheruvanky

发明人： Reddy Sastry Cherukuri ,  Rukmini Cheruvanky

IPC分类号： A61K36/00

CPC分类号： A61K36/899 ,  A23L33/105 ,  A23L33/15 ,  A23L33/16 ,  A23L33/22 ,  A23V2002/00 ,  A23V2250/1586 ,  A23V2250/1588 ,  A23V2250/159 ,  A23V2250/1592 ,  A23V2250/16 ,  A23V2250/161 ,  A23V2250/1612 ,  A23V2250/1614 ,  A23V2250/1642 ,  A23V2250/211 ,  A23V2250/213 ,  A23V2250/21372 ,  A23V2250/21376 ,  A23V2250/304 ,  A23V2250/7042 ,  A23V2250/7044 ,  A23V2250/7046 ,  A23V2250/705 ,  A23V2250/7052 ,  A23V2250/7056 ,  A23V2250/706 ,  A23V2250/708 ,  A23V2250/712 ,  A23V2250/72

摘要： A nutritional fiber derived from stabilized rice bran is described, which is beneficial for treating colon cancer in an individual. Methods for decreasing the likelihood of colon cancer are also described.

摘要翻译： 描述了从稳定的米糠衍生的营养纤维，其有利于治疗个体中的结肠癌。 还描述了降低结肠癌可能性的方法。

公开(公告)号：US07001612B2

公开(公告)日：2006-02-21

申请号：US10074847

申请日：2002-02-13

申请人： Fausto Armonti ,  Donato Mitola ,  Jacobus C. Samson

发明人： Fausto Armonti ,  Donato Mitola ,  Jacobus C. Samson

IPC分类号： A61K47/00

CPC分类号： A61K45/06 ,  A23L33/16 ,  A23V2002/00 ,  A61K31/07 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4188 ,  A61K31/7048 ,  A61K2300/00 ,  A23V2250/72 ,  A23V2250/211 ,  A23V2250/712 ,  A23V2250/1642 ,  A23V2250/1612 ,  A23V2250/1578 ,  A23V2250/161

摘要： A composition for the relief of heat stress, particularly for restoration of electrolyte balance due to passive exposure to heat resulting in excessive transpiration/perspiration, without strenuous physical activity, contains predetermined levels of selected electrolytes including, in part by weight, sodium ion not exceeding 250 parts, at least 100 parts of potassium ion, at least 100 parts of magnesium ion, and carbohydrates not exceeding 2.5% by weight, as needed for organoleptic purposes only. The composition can further include up to 30 parts of zinc, up to 10 parts of manganese, and from 65 to 400 parts of calcium. Furthermore, the composition can contain oligoelements, dermoprotective vitamins and anti-oxidants so as to compensate for the chemical changes which might occur in the skin of a person passively exposed to heat.

摘要翻译： 用于缓解热应激的组合物，特别是用于由于被动暴露于热而导致过度蒸腾/出汗而导致的电解质平衡的恢复而没有剧烈的身体活动，包含预定水平的选定电解质，其中包括部分重量的钠离子不超过 250份，至少100份的钾离子，至少100份的镁离子和不超过2.5重量％的碳水化合物，仅根据感官目的需要。 该组合物还可包含至多30份锌，至多10份锰和65至400份钙。 此外，组合物可以含有稀释元件，皮肤保护性维生素和抗氧化剂，以补偿被动暴露于热量的人的皮肤中可能发生的化学变化。

公开(公告)号：US20060024352A1

公开(公告)日：2006-02-02

申请号：US11236570

申请日：2005-09-28

申请人： Scott Poxon ,  William Bubnis ,  Bruce Sutton ,  Jeffrey Vernon ,  Denise Walters ,  Michael Williams ,  Neil Wittenberg

发明人： Scott Poxon ,  William Bubnis ,  Bruce Sutton ,  Jeffrey Vernon ,  Denise Walters ,  Michael Williams ,  Neil Wittenberg

IPC分类号： A61K47/00 ,  A61K31/56

CPC分类号： A61K31/56 ,  A23L33/11 ,  A23L33/15 ,  A23L33/16 ,  A23V2002/00 ,  A61K9/0056 ,  A61K9/009 ,  A61K9/10 ,  A61K9/1611 ,  A61K9/1652 ,  A61K9/2018 ,  A61K9/2054 ,  A61K9/4866 ,  A61K31/355 ,  A61K31/375 ,  A61K31/51 ,  A61K31/525 ,  A61K31/714 ,  A61K45/06 ,  A61K47/02 ,  A61K2300/00 ,  A23V2250/1592 ,  A23V2250/1598 ,  A23V2250/161 ,  A23V2250/1642 ,  A23V2250/1626 ,  A23V2250/1588 ,  A23V2250/1612 ,  A23V2250/1578 ,  A23V2250/1618 ,  A23V2250/1608 ,  A23V2250/1572 ,  A23V2250/1628 ,  A23V2250/163 ,  A23V2250/1636 ,  A23V2250/702 ,  A23V2250/7044 ,  A23V2250/708 ,  A23V2250/7052 ,  A23V2250/706 ,  A23V2250/7056 ,  A23V2250/712 ,  A23V2250/2136 ,  A23V2250/213 ,  A23V2200/3262 ,  A23V2250/71 ,  A23V2250/714 ,  A23V2250/304 ,  A23V2250/7046 ,  A23V2250/72 ,  A23V2250/705

摘要： The invention provides a nutritional supplement which includes phytosterol to facilitate reduction of cholesterol. The nutritional supplement may be a swallowable tablet, chewable tablet, sachet, capsule or suspension. The invention further provides a method for tableting one fourth to one half of the daily effective dosage of a phytosterol containing nutritional supplement in a practical sized swallowable tablet and a method for reducing blood cholesterol in humans.

公开(公告)号：US20020137796A1

公开(公告)日：2002-09-26

申请号：US09381484

申请日：2000-02-28

发明人： DEBORAH A SCHADE ,  KIMBERLY L MERKEL ,  JAMES W HANSEN

IPC分类号： A61K047/00 ,  A61K031/20

CPC分类号： A61K31/205 ,  A23L33/12 ,  A23L33/40 ,  A23V2002/00 ,  A61K31/202 ,  A61K2300/00 ,  A23V2250/156 ,  A23V2250/1862 ,  A23V2250/1868 ,  A23V2250/70 ,  A23V2250/7046 ,  A23V2250/705 ,  A23V2250/7056 ,  A23V2250/72

摘要： A method for enhancing the growth of preterm infants involving the administration of certain long chain polyunsaturated fatty acids. It is preferred that the infants are administered an infant formula containing a combination of docohexaenoic acid and arachidonic acid.

摘要翻译： 一种增强早产儿生长的方法，涉及给予某些长链多不饱和脂肪酸。 优选给予婴儿含有二十二碳烯酸和花生四烯酸的组合的婴儿配方奶粉。

公开(公告)号：US20190191754A1

公开(公告)日：2019-06-27

申请号：US16219510

申请日：2018-12-13

申请人： MANTRA PHARMA

发明人： Olivier PAQUET ,  Maxime DESLAURIERS

IPC分类号： A23L33/155 ,  A23L33/16 ,  A23L33/00

CPC分类号： A23L33/155 ,  A23L33/15 ,  A23L33/16 ,  A23L33/30 ,  A23V2002/00 ,  A23V2200/30 ,  A23V2200/332 ,  A23V2250/1578 ,  A23V2250/1586 ,  A23V2250/1588 ,  A23V2250/1592 ,  A23V2250/1598 ,  A23V2250/16 ,  A23V2250/1604 ,  A23V2250/1608 ,  A23V2250/161 ,  A23V2250/1612 ,  A23V2250/1614 ,  A23V2250/1626 ,  A23V2250/1642 ,  A23V2250/702 ,  A23V2250/7042 ,  A23V2250/7044 ,  A23V2250/7046 ,  A23V2250/705 ,  A23V2250/7052 ,  A23V2250/7054 ,  A23V2250/7056 ,  A23V2250/7058 ,  A23V2250/706 ,  A23V2250/708 ,  A23V2250/71 ,  A23V2250/7102 ,  A23V2250/7104 ,  A23V2250/7106 ,  A23V2250/712 ,  A23V2250/714 ,  A23V2250/72 ,  A61K33/06 ,  A61K45/06 ,  A61P3/02 ,  A61K2300/00

摘要： The present technology relates to a nutritional formulation for administration to bariatric individuals. The nutritional formulation comprises a multi-nutrients dosage unit; and a minerals dosage unit.

公开(公告)号：US09943602B2

公开(公告)日：2018-04-17

申请号：US14268728

申请日：2014-05-02

申请人： SDG, INC.

发明人： W. Blair Geho ,  John R. Lau

IPC分类号： A61K36/28 ,  A61K47/28 ,  A61K31/198 ,  A61K31/4045 ,  A61K31/4188 ,  C07K16/00 ,  A61K47/24 ,  A23L33/10 ,  A61K47/54 ,  A61K9/127 ,  A61K9/48 ,  A61K39/00

CPC分类号： A61K47/28 ,  A23L33/10 ,  A23V2002/00 ,  A61K9/127 ,  A61K9/4858 ,  A61K31/198 ,  A61K31/4045 ,  A61K31/4188 ,  A61K47/24 ,  A61K47/544 ,  A61K47/557 ,  A61K2039/505 ,  A61K2039/542 ,  C07K16/00 ,  A23V2200/332 ,  A23V2250/72 ,  A23V2250/5432 ,  A23V2200/3262

摘要： The present invention is embodied by a composition capable inducing weight loss in a patient in need thereof.

公开(公告)号：US09889149B2

公开(公告)日：2018-02-13

申请号：US13941625

申请日：2013-07-15

申请人： N.V. Nutricia

发明人： Robert Johan Joseph Hageman

IPC分类号： A61K31/714 ,  A61K31/198 ,  A61K31/4188 ,  A61K36/48 ,  A61K36/81 ,  A61K36/899 ,  A61K38/01 ,  A23L13/60 ,  A23L23/10 ,  A23L33/17 ,  A23L33/175 ,  A23L33/18 ,  A23L33/185 ,  A23L33/19 ,  A61K38/02 ,  A23L33/00 ,  A23L13/40

CPC分类号： A61K31/714 ,  A23L13/424 ,  A23L13/65 ,  A23L23/10 ,  A23L33/17 ,  A23L33/175 ,  A23L33/18 ,  A23L33/185 ,  A23L33/19 ,  A23L33/40 ,  A23V2002/00 ,  A61K31/198 ,  A61K31/4188 ,  A61K36/48 ,  A61K36/81 ,  A61K36/899 ,  A61K38/01 ,  A61K38/02 ,  A61K2300/00 ,  A23V2200/328 ,  A23V2250/0636 ,  A23V2250/061 ,  A23V2250/0628 ,  A23V2250/062 ,  A23V2250/5114 ,  A23V2250/608 ,  A23V2250/61 ,  A23V2250/1882 ,  A23V2250/5106 ,  A23V2250/156 ,  A23V2250/15 ,  A23V2200/332 ,  A23V2250/0618 ,  A23V2250/54252 ,  A23V2250/5488 ,  A23V2250/612 ,  A23V2250/1842 ,  A23V2250/702 ,  A23V2250/712 ,  A23V2250/7042 ,  A23V2250/7052 ,  A23V2250/72 ,  A23V2250/7046 ,  A23V2250/0644 ,  A23V2250/1614 ,  A23V2250/1618 ,  A23V2250/1582 ,  A23V2250/1592 ,  A23V2250/1588

摘要： The invention relates to the use of specific protein and/or peptide fractions having a high aspartate content for regulating plasma glucose concentrations and increasing insulin sensitivity in a mammal. The invention relates to a complete food fortified with aspartate equivalents as well as a supplement rich in aspartate equivalents that is given simultaneously with or even minutes up to an hour prior to the consumption of a meal comprising glucose. The nutritional or pharmaceutical composition contains at least one protein having a high aspartate content, preferably of soy or dairy origin, which is further enriched with aspartate equivalents from another protein and/or free aspartate equivalents. The protein fraction comprises glutamate equivalents in a weight ratio of aspartate equivalents to glutamate equivalents (asp:glu) between 0.41:1 and 5:1.

公开(公告)号：US20170239214A1

公开(公告)日：2017-08-24

申请号：US15503968

申请日：2015-10-13

申请人： The Asan Foundation

发明人： Ki Up Lee ,  Joong Yeol Park ,  Eun Hee Koh ,  Jung Eun Jang ,  In Kyu Lee

IPC分类号： A61K31/385 ,  A23L33/175 ,  A23L33/12 ,  A23L33/00 ,  A61K31/198 ,  A61K9/00

CPC分类号： A61K31/385 ,  A23L33/10 ,  A23L33/12 ,  A23L33/175 ,  A23L33/40 ,  A23V2002/00 ,  A61K9/0019 ,  A61K9/0095 ,  A61K9/08 ,  A61K9/145 ,  A61K9/2018 ,  A61K9/4858 ,  A61K31/198 ,  A23V2200/332 ,  A23V2250/026 ,  A23V2250/0634 ,  A23V2250/156 ,  A23V2250/1578 ,  A23V2250/1592 ,  A23V2250/16 ,  A23V2250/161 ,  A23V2250/1618 ,  A23V2250/1642 ,  A23V2250/702 ,  A23V2250/7042 ,  A23V2250/7044 ,  A23V2250/7052 ,  A23V2250/7056 ,  A23V2250/706 ,  A23V2250/708 ,  A23V2250/712 ,  A23V2250/72

摘要： The present invention provides a composition containing α-lipoic acid and N-acetylcysteine as active ingredients. The mixed composition of α-lipoic acid and N-acetylcysteine of the present invention can reduce a risk of side effects due to drugs with synergetic effects due to merge administration of two drugs, and can be usefully used for preventing or treating obesity with excellent effects of inhibiting a weight gain compared to each single composition containing α-lipoic acid or N-acetylcysteine.

公开(公告)号：US09687555B2

公开(公告)日：2017-06-27

申请号：US14840655

申请日：2015-08-31

申请人： N.V. Nutricia

发明人： Esther Jacqueline Petra De Kort ,  Martine Groenendijk ,  Patrick Joseph Gerardus Hendrikus Kamphuis

IPC分类号： A01N43/04 ,  A61K31/70 ,  A61K47/38 ,  A61K9/00 ,  A61K31/7052 ,  A61K31/7072 ,  A61K33/06 ,  A61K35/60 ,  A61K38/02 ,  A61K47/36 ,  A23L29/262 ,  A23L29/269 ,  A23L33/00 ,  A23L33/115 ,  A23L33/13 ,  A23L33/17 ,  A61K47/42 ,  A61K47/44

CPC分类号： A61K47/38 ,  A23L29/262 ,  A23L29/269 ,  A23L29/272 ,  A23L33/115 ,  A23L33/13 ,  A23L33/17 ,  A23L33/40 ,  A23V2002/00 ,  A61K9/0095 ,  A61K31/7052 ,  A61K31/7072 ,  A61K33/06 ,  A61K35/60 ,  A61K38/02 ,  A61K47/36 ,  A61K47/42 ,  A61K47/44 ,  A61K2300/00 ,  A23V2200/322 ,  A23V2200/302 ,  A23V2250/712 ,  A23V2250/708 ,  A23V2250/7052 ,  A23V2250/706 ,  A23V2250/714 ,  A23V2250/702 ,  A23V2250/72 ,  A23V2250/1588 ,  A23V2250/1614 ,  A23V2250/1608 ,  A23V2250/1612 ,  A23V2250/1642 ,  A23V2250/1868 ,  A23V2250/187 ,  A23V2250/51082 ,  A23V2250/54246 ,  A23V2250/54252 ,  A23V2250/628 ,  A23V2250/5114

摘要： The present invention relates to the use of a taste masking agent selected from the group of starch; cellulose; xanthan gum; gellan gum; alginate; galactomannans such as fenugreek, guar gum, tara gum, locust bean gum, and cassia gum; gum karaya; gum tragacanth; carrageenan; and mixture thereof, for improving one or more of mouth feel, taste, aftertaste and smell of a liquid aqueous nutritional composition comprising a nucleoside and/or a nucleotide. It also relates to a nutritional composition comprising an unsavory nucleoside and/or nucleotide component, having improved sensory characteristics such as improved mouth feel, taste, aftertaste and smell. In particular, it relates to a composition comprising said unsavory nucleoside and/or nucleotide component, in particular comprising an uridine-containing nucleoside and/or a nucleotide in combination with an unsavory edible oil, such as a fish oil.

公开(公告)号：US20170055562A1

公开(公告)日：2017-03-02

申请号：US15253756

申请日：2016-08-31

申请人： D. Holmes Morton

发明人： D. Holmes Morton

IPC分类号： A23L33/00 ,  A23L2/52 ,  A23L33/175

CPC分类号： A23L33/30 ,  A23L2/52 ,  A23L33/15 ,  A23L33/175 ,  A23V2002/00 ,  A23V2200/30 ,  A23V2250/032 ,  A23V2250/044 ,  A23V2250/0632 ,  A23V2250/0644 ,  A23V2250/0648 ,  A23V2250/0654 ,  A23V2250/306 ,  A23V2250/7044 ,  A23V2250/7046 ,  A23V2250/705 ,  A23V2250/7056 ,  A23V2250/706 ,  A23V2250/72

摘要： Described is a nutritional formula, also referred to as a nutritional formulation, for dietary management of a propionic metabolism disorder, such as propionic acidemia.

摘要翻译： 描述了一种营养配方，也称为营养配方，用于膳食管理丙酸代谢紊乱，如丙酸血症。